Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14759646 | 0.77 | GBA1 (0.37) | — | |
| SCHEMBL9368807 | 0.77 | ALDH1A1 (0.32) | L3MBTL1 | |
| SCHEMBL11360985 | 0.76 | ALDH1A1 (0.34) | L3MBTL1 | |
| SCHEMBL756668 | 0.71 | TAAR1 (0.33) | — | |
| SCHEMBL28206939 | 0.69 | GAA (0.35) | — | |
| SCHEMBL6842695 | 0.68 | ALDH1A1 (0.45) | TSHRMAPK1L3MBTL1 | |
| SCHEMBL27978078 | 0.67 | LTA4H (0.39) | TSHR | |
| SCHEMBL12093784 | 0.67 | ADH1A (0.32) | — | |
| SCHEMBL27597183 | 0.66 | LTA4H (0.35) | TSHRMAPK1RECQLL3MBTL1 | |
| SCHEMBL27597181 | 0.66 | LTA4H (0.35) | TSHRMAPK1RECQLL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107285334-B | A kind of method and catalyst of synthesis in solid state AEI type molecular sieve | 中触媒新材料股份有限公司 | 2019-05-10 | — | — | CN | claimed |
| US-7288613-B2 | N-alkoxy-4,4-dioxy-polyalkyl-piperidine compounds, their corresponding N-oxides and controlled radical polymerization therewith | CIBA SPECIALTY CHEMICALS CORP. (US) | 2007-10-30 | — | — | US | disclosed |
| US-20060149011-A1 | N-alkoxy-4,4-dioxy-polyalkyl-piperidine compounds, their corresponding N-oxides and controlled radical polymerization therewith | NESVADBA PETER | 2006-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060149011-A1 | N-alkoxy-4,4-dioxy-polyalkyl-piperidine compounds, their corresponding N-oxides and controlled radical polymerization therewith | ALKBH2, ALKBH3, ALKBH5 | TSHR 4785/4885MAPK1 3674/4885RECQL 4200/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.